Idgie Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: flat any-dose compounded semaglutide at $149 a month with no membership fee
Idgie Health scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $134 a month; its compounded semaglutide, at $149, is 25% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
microdose tier; standard plans start at $149/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Idgie Health, the brand name of Feel Better Health Group, LLC, sells compounded semaglutide and tirzepatide online, prescribed by a named Seattle physician group and filled by a named Houston compounding pharmacy. It charges the same price at every dose and also sells microdose injections and needle-free dissolving tablets that pair the drug with the anti-nausea medicine ondansetron. Month to month, semaglutide is $149 and tirzepatide $229; 3 and 6-month plans paid upfront bring semaglutide down to about $114 a month.
Is Idgie Health legit?
Yes. Idgie Health is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.7/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an Idgie Health promo or coupon code?
We know of no promo or coupon code for Idgie Health. Its listed price is $134 a month. Coupon sites advertising "Idgie Health discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Idgie Health compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Idgie Health
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Ivim Health
Best for: coaching and unlimited provider visits bundled into a 12-month compounded program
Editorial score · methodology
Idgie Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $134/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How Idgie Health scores
Six columns, each one computed from something Idgie Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.1/10$149/month is 25% below the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Idgie Health
Last checked October 2026- Checked the listed price across 6 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Idgie Health
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Idgie Health involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Idgie Health shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Idgie Health which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $149, tirzepatide $229. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Idgie Health serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Idgie Health
- Phone
- 907-312-5564
- Idgie Health offers email support
Cancelling Idgie Health
Taken from the terms Idgie Health publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Month to month, or a 3 or 6-month plan charged in full upfront that renews at the same price until canceled
- Refund policy
- "all sales are final"
- Early-termination fee
- None
Medications Idgie Health lists
Idgie Health lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
$149 a month at every dose, with the provider evaluation, medication, injection supplies and shipping included. A 3-month plan costs $387 upfront (about $129/mo) and a 6-month plan $687 upfront (about $114/mo); both renew at the same price until you cancel, and medication still ships monthly.
$229 a month at every dose. A 3-month plan costs $557 upfront (about $185/mo) and a 6-month plan $1,029 upfront (about $171/mo), each renewing at the same price until you cancel.
A needle-free dissolving tablet that combines semaglutide with ondansetron, a prescription anti-nausea medicine. $287 month to month, or $747 upfront for 3 months (about $249/mo). No 6-month option is listed.
A needle-free dissolving tablet that combines tirzepatide with ondansetron, a prescription anti-nausea medicine. $287 month to month, or $747 upfront for 3 months (about $249/mo). This product has its own page but is not linked from the site menu.
A low-dose semaglutide plan at $134 month to month, or $377 upfront for 3 months (about $125/mo). Idgie itself describes microdosing as an off-label approach.
A low-dose tirzepatide plan at $179 month to month, or $497 upfront for 3 months (about $165/mo). Idgie itself describes microdosing as an off-label approach.
Check the price yourself before you pay
Every figure here comes from Idgie Health's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $149 a month, 25% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $229 a month, 15% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Idgie Health
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Idgie Health charges
Idgie Health charges $134/month for its microdose tier; its standard plans start at $149/month and hold that rate across every dose.
- Compounded semaglutide (injection): $149/month
- Compounded tirzepatide (injection): $229/month
- Compounded semaglutide (tablet): $287/month
- Compounded tirzepatide (tablet): $287/month
- Compounded semaglutide (microdose injection): $134/month
- Compounded tirzepatide (microdose injection): $179/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Idgie Health's $149 is genuinely below the middle, not just advertised that way. Before you pay, compare Idgie Health's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Live Vital dispenses semaglutide and tirzepatide from $130/month, which makes it the fair comparison to run before you commit here.
What Idgie Health dispenses
Idgie Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder. Idgie Health also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Idgie Health at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Idgie Health tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to Idgie Health. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Idgie Health will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Idgie Health bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- injections are the thing keeping you from starting
Our read
Idgie Health competes on price without an obvious sacrifice elsewhere: $149/month for compounded semaglutide, no FDA warning letters.
The Bottom Line
Idgie Health scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $134 a month; its compounded semaglutide, at $149, is 25% below the $199 median among the sellers we compare.
Before you pay Idgie Health
Starting at $134 a month. Check today's price, then start the intake.
Where Idgie Health is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Ivim Health.
If none of these fits, our guide to alternatives to Idgie Health sets more sellers in the same category beside Idgie Health on price, states and what the price includes.
Frequently Asked Questions
How to check Idgie Health yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Idgie Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Idgie Health's current pricing
Plans start at $134 a month. Whether you qualify is a clinician's decision, made after your intake.